The Danish Alzheimer Intervention Study: Rationale, Study Design and Baseline Characteristics of the Cohort by Waldemar, Gunhild et al.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Methods in Neuroepidemiology 
 Neuroepidemiology 2011;36:52–61 
 DOI: 10.1159/000322942 
 The Danish Alzheimer Intervention
Study: Rationale, Study Design and 
Baseline Characteristics of the Cohort 
 G. Waldemar  a    F.B. Waldorff  a, b    D.V. Buss  a    A. Eckermann  a    N. Keiding  c    
S. Rishøj  a    V. Siersma  b    J. Sørensen  d    L.V. Sørensen  a    A. Vogel  a 
 a   Memory Disorders Research Group, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, 
 b   Research Unit and Department of General Practice and  c   Department of Biostatistics, Institute of Public Health, 
University of Copenhagen, and  d   Centre for Applied Health Services Research and Technology Assessment, 
University of Southern Denmark,  Copenhagen , Denmark 
the mean age of the patients and caregivers was 76.2 and 
66.0 years, respectively.  Conclusion: The study will explore 
the added value of a multifaceted intervention programme 
and contribute to the design of future interventions for pa-
tients with mild dementia and their caregivers. 
 Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Alzheimer’s disease (AD) and other dementia disor-
ders are characterized by progressive decline in cognitive, 
social and occupational function and are often associated 
with affective symptoms and behavioural disturbances. 
The majority of the patients are living in their own homes 
and require increasing assistance and supervision from 
caregivers, often a spouse. The role as a family caregiver 
for a patient with dementia is associated with a greater risk 
of developing stress and somatic and psychiatric health 
problems  [1–3] . Several studies have indicated that coun-
selling and psychosocial interventions for caregivers may 
have a significant positive effect in patients with moderate 
to severe AD  [4–6] as well as in their caregivers  [5, 7–16] . 
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 Abstract 
 Background: There is a lack of appropriately designed trials 
investigating the efficacy of psychosocial interventions for 
patients with mild dementia and their family caregivers. This 
paper reports the rationale and design of the Danish Alz-
heimer Disease Intervention Study and baseline characteris-
tics of the cohort.  Methods: The study was a 1-year multicen-
tre randomized controlled rater-blinded trial with random-
ization to follow-up and a multifaceted semitailored 
intervention programme or to follow-up only (with exten-
sion of follow-up to 3 years). The intervention included a 
counselling programme, teaching courses, written informa-
tion and logbooks. The outcomes included clinical efficacy 
parameters, patient satisfaction and health economic conse-
quences.  Results: A total of 330 patients and their 330 care-
givers were included during a period of 18 months. The ma-
jority (65.2 %) of the caregivers were spouses. At inclusion 
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In general, however, results have been inconsistent, the 
quality of studies has been poor, and there is a need for 
appropriately designed trials  [17] . For policy makers and 
service planners, who work with carer and patient support 
in dementia, good quality evidence is crucial for identify-
ing who would benefit from the service and when. While 
there is an increasing awareness of the importance of ear-
ly and continuous support and care, the majority of the 
patients have no or little access to diagnostic evaluation, 
treatment, and follow-up during the course of their dis-
ease  [18, 19] . With increased awareness and better diag-
nostic methods many patients with progressing neurode-
generative dementia disorders are now diagnosed in the 
very early phase of their disease. Patients with very mild 
dementia often have nearly full autonomy and may re-
quest more attention and specific counselling programmes 
directed towards their own needs. Hence, it is necessary 
to develop and validate support programmes, which focus 
specifically on the needs of patients with mild dementia 
and their caregivers, and which include psychosocial sup-
port  for  the  patient as well as for the caregiver. The aim 
of the Danish Alzheimer Disease Intervention Study 
(DAISY) was to evaluate and explore clinical effect, pa-
tient satisfaction and health economic consequences of a 
multifaceted and semitailored intervention programme 
in patients with mild dementia and their caregivers, in 
whom follow-up secured referral to conventional local 
support programmes where available and relevant.
 We hypothesized that the multifaceted and semitai-
lored intervention programme offered to the patients and 
their primary caregivers during the first year after the 
diagnosis might prevent the emergence of depressive 
symptoms and improve the quality of life in patients as 
well as in caregivers, and perhaps even stabilize the pa-
tients’ cognitive function for some time. This paper re-
views current methodological issues in psychosocial in-
terventions and reports the rationale and design of the 
DAISY study, and the baseline characteristics of the co-
hort.
 Material and Methods 
 Study Design 
 The study design and reporting adhere to the Consoli-
dated Standards for Reporting Trials Statement (www.consort-
statement.org)  [20] . The study design was compatible with the 
quality criteria and recommendations proposed by the Cochrane 
systematic review on support for carers of people with AD, which 
was available at the time of the initiation of the study  [21] and 
later updated  [22] .
 As shown in  figure 1 , the study was designed as a 1-year mul-
ticentre randomized controlled rater-blinded trial (RCT) with
1: 1 randomization to follow-up only or to follow-up with the ad-
dition of the DAISY intervention, a multifaceted semitailored in-
tervention programme, described in detail below. Two years after 
study start supplementary funding was obtained to extend the 
follow-up with a study visit 3 years after inclusion.
 To randomize participants we used a central allocation pro-
cess by a third party unaware of and concealed for the DAISY in-
vestigators. The allocation process was initiated after patient and 
caregiver identity and key baseline data had been registered in the 
central project office. The randomization was done using a com-
puter programme (Stat-Direct version 2.3.7). We used a random 
block size algorithm to prevent imbalance between the allocation 
groups. Patients were stratified by centre, MMSE score (20–23; 
24–30) and use (or nonuse) of symptomatic antidementia drugs. 
The assignment to group was done via letters from the central of-
fice to the local study coordinators. As described below, a range 
of primary and secondary quantitative outcome measures from 
standardized tests and scales, from interview data or from regis-
try-based information were collected at baseline and at 6, 12 and 
36 months. The randomization code and study results were not 
opened until after the last patient had completed the visit at 3 
years. In the intervention group, patient and caregiver compliance 
Baseline visit
Follow-up
165 patients and 165 caregivers
Follow-up and
DAISY intervention
165 patients and 165 caregivers
6 months
follow-up
6 months
follow-up
12 months
follow-up
12 months
follow-up
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follow-up
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Registry-based follow-up
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 Fig. 1. DAISY trial design. The bar illustrates the duration of the 
intervention in the intervention group. The primary efficacy pa-
rameters were defined at 1 year after baseline. 
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and satisfaction with the intervention programme, and quali-
tative aspects of the intervention were assessed in separate sub-
studies.
 Patients 
 Recruitment. The study was conducted in 5 counties, repre-
senting rural and urban districts, in Denmark ( fig. 2 ), and inclu-
sion took place in 1 centre in each county during a period of 18 
months. In each of the 5 counties information regarding the proj-
ect was provided to all general practitioners, to private practice 
neurologists and psychiatrists, as well as to all hospital depart-
ments involved in diagnostic evaluation of patients with demen-
tia. The local study coordinator and a designated physician in 
each of the local memory clinics assessed patients regarding in- 
and exclusion criteria.
 Inclusion Criteria. The study included community-dwelling 
patients with a clinical diagnosis of probable AD, mixed AD with 
vascular components or dementia with Lewy bodies (DLB), estab-
lished within the past 12 months; age  6 50 years; mild dementia 
with MMSE score  6 20; a primary caregiver with close contact to 
the patient who was willing to participate in the study and the 
intervention; and informed consent from the patient and the care-
giver. All patients met DSM-IV  [23] for dementia and the 
NINCDS-ADRDA criteria for probable AD  [24] or the McKeith 
criteria for DLB  [25] . Participants classified as mixed AD were 
patients with probable AD who had vascular changes on cranial 
CT, which may contribute to their symptoms.
 Exclusion Criteria. Patients with severe somatic or psychiatric 
comorbidity (including impaired hearing or vision), which would 
significantly impair their cooperation with the programme, were 
excluded. Patients participating in other intervention studies and 
patients living in a nursing home at baseline were also excluded.
 Primary Caregivers 
 A primary caregiver was defined as the informal caregiver 
who was the main person responsible for the informal care to the 
patient and who had regular contacts (at least weekly) with the 
patient. For patients who had  1 1 primary caregiver, the invitation 
to join this study was given to only 1 person, at the patient’s choice.
 Baseline and Follow-Up Visits 
 Patients and their primary caregivers participated together in 
all visits. The baseline visit took place prior to randomization and 
was performed by the local study coordinator in the local memo-
ry clinic. The follow-up visits were home visits performed at 6, 12 
and 36 months by independent raters unaware of the randomiza-
tion code. The raters were not involved in the intervention pro-
gramme, and they were not employed in the same institutions as 
the study coordinators and counsellors. Patients and caregivers 
were instructed to try not to reveal which treatment arm they were 
in. The efficiency of concealment was checked using a question-
naire to the raters at the end of each follow-up visit. None of the 
raters visited the same patient-caregiver couple more than once.
 Drop-Outs 
 For patients dropping out of the study, the date and reason for 
dropout was registered. If a patient dropped out for whatever rea-
son, the caregiver was not allowed to continue in the study. If a 
primary caregiver dropped out, she/he was replaced with another 
primary caregiver if possible, in order to continue assessment of 
proxy-rated parameters (whereas scales rating caregiver health 
status were discontinued). If no replacement was possible, only 
the patient continued in the study, and proxy-rated assessments 
were discontinued.
 Roles and Training of Study Coordinators, Raters and 
Monitors 
 In each of the 5 centres a study coordinator was responsible for 
recruitment, baseline assessments, implementation of the multi-
faceted and semitailored intervention, all counselling sessions 
and project coordination. The study coordinators were all desig-
nated specialist nurses with several years of experience in the field 
of dementia and in counselling. Prior to the initiation of the study 
the study coordinators participated in a 4-day centralized course, 
where they were instructed in the rationale and design of the 
study, in the intervention programme, in basic concepts of patient 
and caregiver intervention, and in the concepts and objectives of 
the specific counselling programme applied in this study. The 
course also contained formalized teaching of communication and 
counselling. Throughout the study intervention period, the study 
coordinators were offered supervision on a regular basis at 8 cen-
tralized follow-up sessions and at regular site visits by specialists 
from the coordinating study centre. The raters were nurses, ther-
apists and other health professionals from the local municipalities 
or hospitals. They were responsible for follow-up of all patients 
 Fig. 2. Map of Denmark showing the 5 counties involved in the 
DAISY study: Ribe, Ringkøbing, Vestsjaelland and Roskilde 
counties, and central Copenhagen (Frederiksberg and Copenha-
gen municipalities). 
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and assessments at 6, 12 and 36 months. Both study coordinators 
and raters participated in centralized training sessions for the as-
sessment of primary and secondary efficacy parameters. Central 
study monitors observed the progress of the study in each centre 
and checked case report forms for completeness and consistency 
throughout the study.
 The DAISY Intervention: A Multifaceted and Semitailored 
Intervention Programme 
 The novel multifaceted and semitailored intervention pro-
gramme was designed to comprise counselling, information and 
support to patients with mild dementia as well as to their primary 
caregivers during the initial months after a diagnosis had been 
established ( fig. 3 ). The objective of the programme was to prevent 
the emergence of depressive symptoms and further impairment 
of health-related quality of life in patients as well as in caregivers, 
and perhaps even stabilize cognitive function in the patients for 
some time. The philosophy was to focus on positive resources, 
intact functions and retained skills and activities that the patients 
could still take part in. Administered by the local study coordina-
tor in each centre, the programme was carried out in the interven-
tion group only and initiated within the first month after inclu-
sion. Having 5 key components, part of the intervention was tai-
lored to the needs of the individual patient and/or caregiver, while 
other parts of the programme were based on group intervention. 
The participants were encouraged to take advantage of all com-
ponents in the intervention programme as much as possible. 
Counselling sessions were planned on a running basis, while 
group-based teaching courses were scheduled to start when a suf-
ficient number of participants had been allocated to the interven-
tion arm. Thus, for logistical reasons the duration of the full in-
tervention programme could vary from 8 to 12 months.
 Counselling Sessions 
 The counselling aimed to prevent or reduce depressive symp-
toms, impairment of health- related quality of life and loss of so-
cial network. The counselling programme was based on con-
structivist principles  [26] : the principles and methodology were 
anchored on the dynamics that characterizes the patient and the 
caregiver’s everyday life. The counselling was based on a philo-
sophical approach in which each patient or caregiver was given 
the possibility of expressing his/her own life story and what is of 
personal importance and of great value to the individual. The 
counsellor offered the patient and the caregiver guidance with 
common decision-making, advice and activities that help the par-
ticipants to construct a meaningful life.
 At the initial counselling visit well-structured written notes 
were established. The notes were constructed to reflect the indi-
vidual strengths and needs of the patient and the caregiver in 4 
related areas: daily life, social network, pleasures and activities. 
The written notes were used to focus follow-up sessions, with the 
aim of improving coping strategies and to empower the patient 
and caregiver to focus on the positive factors and resources in 
their lives, according to the principles of self-validation. Self-val-
idation is the process of recognizing and transcending the sense 
of self by various means to appreciate the unconditional value and 
meaning of our personal existence  [27] .
 The counselling sessions were conducted by the local study 
coordinator in the home of the patient or in the hospital-based 
memory clinic. It was composed of: (a) 2 sessions with the patient 
and caregiver, (b) 2 sessions with the patient alone, (c) 2 sessions 
with the caregiver alone, and (d) 1 optional network session with 
the patient, caregiver and family network.
 Courses 
 The aim of the courses was to provide patients and caregivers 
with basic information about dementia and its consequences and 
about living and coping with dementia. The courses also aimed 
to provide a forum for patients and caregivers to exchange experi-
ences and coping strategies. Two parallel lines were aimed at pa-
tients and caregivers, respectively. The courses for patients took 
place simultaneously with the courses for their caregivers, but in 
a separate classroom. In each line the course programme included 
5 scheduled sessions for groups of 12 participants. Each session 
included a standardized agenda with information on key topics 
related to dementia: general information about dementia, legal 
aspects, living with dementia, support to people with dementia 
and their caregivers, and a summary session with miscellaneous 
topics. The sessions were supported by written information pro-
duced specifically for patients and caregivers in this study. Fur-
thermore, support group activities with open agendas were con-
ducted at the end of each session. Here, the patients (or caregivers) 
could discuss topics and questions of their interest and get infor-
mal advice from other patients (or caregivers). All courses were 
coordinated by the local study coordinator, and local health pro-
fessionals in the field of dementia were invited as teachers. Volun-
teers were invited to assist the teacher in the course sessions for 
patients.
 Information Folder 
 A comprehensive information folder with structured informa-
tion sheets about dementia and related aspects was developed spe-
cifically for this study and provided to all participants in the in-
tervention group. The aim of the folders was to provide the par-
ticipants with written information, which would support the 
information given at counselling sessions and teaching courses 
The DAISY intervention
Baseline
visit
12 months
First counselling
Course
2-hour sessions
5 weeks
Final
counselling
session
Family counselling
Information folders
Follow-up counsellings
Outreach telephone counselling
 Fig. 3. Schematic illustration of the temporal relationship be-
tween the components of the DAISY intervention. 
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and also to serve as a reference guide later in the course of the de-
mentia disease after completion of the intervention programme. 
There were separate and different folders for patients and for care-
givers. The folders contained chapters on causes of dementia, di-
agnosis and treatment, legal aspects in relation to dementia, and 
sources and contact details for social support.
 Outreach Telephone Counselling 
 The aim of outreach telephone counselling was to ensure reg-
ular contact and to follow up on issues discussed during the indi-
vidual counselling sessions. At inclusion, patients and caregivers 
decided which one of them should receive the calls. During the 
intervention phase the study coordinator contacted the partici-
pants approximately 5–8 times with 3- to 4-week intervals. The 
calls focused on issues discussed at the individual sessions and 
education courses, but sometimes the conversations included 
other issues relevant to the individual participant.
 Logbook 
 Patients and caregivers were each supplied with a logbook 
where they were free to write information and thoughts about 
their daily life. The logbooks aimed to encourage patients and 
caregivers to make notes about their daily life and prepare for the 
counselling sessions. Use of the logbooks in the counselling ses-
sions was optional.
 Follow-Up Intervention 
 Attempts were made to provide equal treatment for both in-
tervention and control participants in all respects other than the 
add-on study intervention. At every study visit participants in 
both groups were interviewed about their current symptoms and 
daily life and informed about available support programmes (if 
any) in their local community, and they were free to participate 
in those during the study. Participation in other local support ac-
tivities was registered for both groups. Identified special needs led 
to referral to local care facilities when available and relevant.
 Primary Outcome Parameters 
 Since this is one of the first studies to examine the effect of 
support and counselling programmes in patients with very mild 
dementia, no consensus exists with respect to gold standards for 
documenting efficacy. The selection of primary and secondary 
efficacy parameters (listed in  table 1 ) for this study was based on 
the specific aims of the intervention and on the outcome in previ-
ous similar intervention studies in patients with more advanced 
dementia. Although the study follow-up was extended to 3 years, 
the primary outcome parameters were defined for the patients 
and caregivers at the end of year 1. In the patients the primary 
outcomes were the emergence of depressive symptoms, proxy-rat-
ed health-related quality of life and global cognitive performance 
(change from baseline at 1 year). In the caregivers the primary 
outcomes were emergence of depressive symptoms and self-rated 
health-related quality of life (change from baseline at 1 year).
 Other Quantitative Outcome Parameters 
 In addition, a wide range of secondary outcome variables were 
included ( table 1 ). Two questionnaires, 1 for the patient and 1 for 
the caregiver, were used to assess additional health issues, social 
network, content, legal aspects, knowledge of dementia and driv-
ing. The caregiver questionnaire was completed by the caregiver, 
while the patient questionnaire was completed by the rater and 
based on an interview with the patient. Long-term follow-up data 
for mortality, morbidity, institutionalization and health care uti-
lization will be drawn from national registries. The methods for 
assessing health care costs and private costs are described in a 
separate paper  [28] .
 Data Analysis 
 Comparisons of patient and caregiver characteristics and study 
outcomes at baseline between randomization groups will be done 
by t tests for continuous variables and   2 tests for categorical vari-
ables. At the 6-, 12- and 36-month follow-up, the outcomes in the 
2 randomization groups will be evaluated by the mean of their ob-
served values and the mean change from baseline; comparison be-
tween randomization groups will be done by t tests in which sub-
jects with missing values are omitted. Additionally, the difference 
in development of the primary outcomes over the follow-up period 
between randomization groups will be investigated in linear mixed 
models. Here, to adjust for possible bias because of differential 
dropout from the study, the assessment available at the 6-, 12- and 
36-month follow-up will be weighted by the inverse of an estimate 
of the probability of staying in the study  [29, 30] . These probabilities 
will be estimated from the data in logistic regression models for 
death and dropout with the dyad’s characteristics and the observed 
primary outcomes from previous visits as covariates. Difference in 
mortality and institutionalization between the randomization 
groups will be evaluated by a hazard ratio from a Cox regression 
model. Statistical significance will be assessed at a 5% level. Adjust-
ment for multiple testing will be done by the Bonferroni method.
Table 1.  Primary and secondary efficacy parameters
Primary efficacy parameters
Patient:
Depressive symptoms (Cornell’s depression scale) [40]
Proxy-rated health-related quality of life (EuroQoL VAS) [41]
MMSE [42]
Caregiver:
Depressive symptoms (Geriatric Depression Scale, GDS-30) [43]
Health-related quality of life (EuroQoL VAS) [41]
Secondary efficacy parameters 
Health-related quality of life in patients (proxy-rated EuroQoL 5D and VAS,
Quality of life Alzheimer’s disease scale QOL-AD) [41, 44]
Health-related quality of life in caregiver (EuroQoL 5D and VAS) [41]
Behavioral symptoms: Neuropsychiatric Inventory Questionnaire
(NPI-Q) [45, 46]
Activities of daily living (ADCS-ADL) [47]
Insight scale [48]
Resource utilization in patient and caregiver (Resource Utilization in
Dementia, RUD) [49]
Health care resource utilization and costs
Registry-based assessment of health care utilization and key social and
health-related events from 12 months before inclusion and during
5 years of follow-up:
Time to nursing home placement and death
Number of hospital contacts in patient and caregiver
Comorbidity and use of drugs in patient and caregiver
Patient and caregiver content with intervention, public services and network 
Patient and caregiver knowledge and attitudes about key issues in dementia
D
ow
nl
oa
de
d 
by
: 
13
7.
10
8.
70
.7
 - 
1/
29
/2
01
7 
1:
08
:1
4 
PM
 Danish Alzheimer Intervention Study  Neuroepidemiology 2011;36:52–61 57
 Power Calculations 
 Based on mean scores and score variations for MMSE, Euro-
QoL VAS, Cornell Depression Scale and GDS from previous stud-
ies in other similar AD populations  [15, 31–33] we estimated that 
a group size of 165 was needed in order to detect a minimum ef-
fect size (defined as the difference between groups for mean 
change from baseline to 1 year in observed scores) of 1.2 (MMSE), 
2.0 (Cornell), 1.8 (GDS), 6.0 (EuroQoL VAS) with type I error 5% 
and type II error 10%. The calculations were based on an esti-
mated dropout rate of 20% at year 1. The minimum effect sizes 
were partly arbitrarily set, partly defined from outcomes in previ-
ous intervention studies  [15, 31, 32] .
 Compliance 
 In the intervention group compliance was defined as the rate 
of adherence with the schedule for the major components of the 
multifaceted intervention programme. Thus, patients with satis-
factory compliance were defined as patients who had participated 
with their caregivers in at least 3 counselling sessions (not includ-
ing the optional network session) and in at least 3 teaching course 
sessions.
 Evaluation of Participants’ Satisfaction with the Intervention 
Programme 
 In the intervention group evaluation forms were used at 12 
months to quantitatively assess patient and caregiver satisfaction 
concerning each component in the add-on intervention pro-
gramme and overall satisfaction with the programme.
 Qualitative Study 
 A separate qualitative study used individual semistructured 
in-depth interviews of selected patients and caregivers from the 
intervention group in order to study the experienced outcome of 
the intervention in qualitative terms. The intervention group 
evaluation and the qualitative study were conducted and reported 
prior to the completion of follow-up in the RCT  [34] .
 Ethics 
 The DAISY trial was conducted in accordance with the Hel-
sinki declaration and evaluated by the local Scientific Ethics 
Committee [j. nr. (KF) 02-005/04]. All patients and caregivers 
gave informed consent to participation in the study, which was 
approved by the Danish Data Protection Agency (j. nr. 2003-
41-3178) and registered in the Clinical Trial Database (www.
controlled-trials.com/ISRCTN74848736).
 Results 
 In total 330 patients (151 males and 179 females), of 
whom 30.9% lived alone, were included in the study dur-
ing a period of 18 months. Their mean age was 76.2 years 
(range = 54–92), while the mean age of the 330 primary 
caregivers (110 males and 220 females) was 66.0 years 
(range = 22–90). The majority of the caregivers were 
spouses (65.2%). Of the 330 patients, 72.4% had been di-
agnosed as having AD, 25.9% had mixed AD, and 2.7% 
met the criteria for DLB. Most patients received antide-
mentia treatment with either a cholinesterase inhibitor 
(93.3%) or memantine (1%).
 Discussion 
 To our knowledge, this prospective study is the largest 
randomized controlled trial to date to investigate the ef-
ficacy and cost-effectiveness of an intensive support and 
counselling programme for patients in the early phase of 
AD and their caregivers. With access to national regis-
tries for health and social care, the study offers a unique 
opportunity to follow the long-term outcome and bene-
fits of the intervention.
 It is well recognized that caring for a family member 
with dementia is a challenging task associated with im-
paired quality of life, and increased risk for depression 
and other health problems  [1, 2] , and that monitoring 
caregiver burden and quality of life is an important and 
integral task of dementia care. The beneficial effect of a 
wide range of interventions in order to enable caregiver 
coping, reduce caregiver burden and improve caregiver 
quality of life is well recognized from clinical practice 
and numerous previous studies. The most common in-
terventions are training and education programmes, in-
formation-technology-based support, respite care, home 
care service, support groups and technical aids  [5, 7–12] . 
Most, however, are directed towards caregivers to pa-
tients with moderate to severe dementia.
 With advancing medicine and increased public aware-
ness of dementia more patients are diagnosed in the ear-
ly phase of dementia, when they may still have a relative-
ly well preserved autonomy and often request individual 
counselling, information and training. Thus, a psychoso-
cial intervention programmes in mild dementia must be 
adjusted to the special needs of caregivers and at the same 
time include interventions directed towards the patient.
 The DAISY Intervention Programmes 
 The initiation of this study was based on experiences 
in our own memory clinic from counselling and teaching 
programmes for patients with mild dementia and their 
caregivers. We designed the DAISY intervention as a 
multifaceted and semitailored intervention programme, 
which aimed to prevent the emergence of depressive 
symptoms and impairment of health-related quality of 
life in patients as well as in caregivers, and perhaps even 
stabilize the functional status for some time. The pro-
gramme comprised counselling, information and sup-
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port to patients with mild dementia as well as to their 
primary caregivers during the initial months after a di-
agnosis had been established. Rather than focusing on 
compensation for lost functional abilities, the philosophy 
of the counselling programme was to focus on positive 
resources, intact functions and retained skills, and ac-
tivities that the patients could still take part in. In order 
to ensure regular contacts and to follow up on issues dis-
cussed in the individual counselling sessions outreach 
telephone counselling was conducted at regular intervals. 
 The aim of the courses was to provide patients and care-
givers with basic information about dementia and its con-
sequences and about living and coping with dementia. 
The courses also aimed to provide a forum for patients 
and caregivers to exchange experiences and coping strat-
egies. The counselling and courses were supported by 
written information and log books to be kept by the pa-
tients and caregivers. A unique feature of the programme 
was the consistent 2-lined design with activities and in-
formation specifically directed towards the patients as 
well as the caregivers. Another unique feature was the 
semitailored design with some components adapted to 
the needs of the individual patient or caregiver and with 
other components common for all participants. The in-
clusion of the family network in one of the counselling 
sessions, at the discretion of the patient, aimed to ensure 
information to all, to prevent stigmatization, to identify 
important resources in the network and to enable the 
caregiver to recruit a larger network, when needed.
 The intention of the programme was not only to inves-
tigate the short-term effect in the period where the inter-
vention took place. By trying to empower both patients 
and caregivers to understand their symptoms and situa-
tions better, and by teaching coping strategies, the inter-
vention and counselling was intended to have a long-term 
effect.
 Follow-Up 
 For ethical reasons and in order not to leave any par-
ticipants in the control group without any intervention 
except blinded rating, both groups received a standard-
ized follow-up intervention. At every study visit par-
ticipants in both groups were interviewed about their 
current symptoms and daily life and informed about 
available support programmes (if any) in their local com-
munity, and they were free to participate in those during 
the study. Any specific and urgent needs identified by the 
study raters were handled by referral to the general prac-
titioner or local care programmes, when relevant. Thus, 
these attempts to provide equal treatment of both inter-
vention and control participants in all respects other than 
the DAISY intervention left all participants with a service 
well above the level of usual care, as patients with demen-
tia in Denmark, if diagnosed, are often left without any 
follow-up and without any systematic monitoring of 
caregiver needs  [18, 19] .
 Selection of Patients 
 We included only patients with mild recently diag-
nosed dementia and only patients who had been offered 
a conventional diagnostic evaluation by a local specialist 
in dementia. By requiring appropriate diagnostic evalua-
tion we wanted to prevent patients with questionable de-
mentia and nonprogressive cognitive disorders from en-
tering our programme. We did not allow patients with 
frontotemporal dementias in the programme, as they of-
ten have other needs. They may have difficulties in coop-
erating with the programme, and it may be difficult to 
mix patients with different disorders in the same ses-
sions. Patients and caregivers were invited to the study 
regardless of their expected or expressed needs for inter-
vention. Thus, the inclusion into the study was not re-
stricted to patients and caregivers with active help-seek-
ing behaviour. Participation in the study programme was 
quite demanding, particularly for those entering the 
DAISY intervention group. Adherence to the many coun-
selling meetings and courses may be difficult for some, 
particularly for those with impaired somatic health sta-
tus, busy caregivers, and for those living far away from 
the study centre. By the mere fact that a diagnosis and 
caregivers were required for entering the study, our pop-
ulation was selected. However, based on previously re-
ported data on self-rated health and social performance 
 [35, 36] , the profile of patients and caregivers in our study 
was similar to that of typical drug trials and other clinical 
cohorts in mild AD  [31, 32, 37] .
 Outcome Parameters 
 There was only little guidance from the literature for 
the selection of primary outcome parameters and for a 
priori sample size calculations. Our choices were based 
on the objectives of the DAISY intervention, on results in 
previous psychosocial intervention studies for caregivers 
to patients with more advanced dementia and on drug 
trials in mild AD. However, a wide range of addition-
al quantitative outcome parameters were included. A 
unique feature of the study is the potential for follow-up 
of the cohort far beyond the actual study visits by using 
information in the systematic and comprehensive Danish 
health care registries.
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 Assessment of Efficacy in Psychosocial Interventions 
 In a recent systematic review aimed to assess the ef-
fectiveness of interventions based on information and 
support provision for informal caregivers of people with 
dementia in community settings 44 randomized studies 
were included according to assessment of quality and rel-
evance  [17] . Overall the methodological quality of the 
studies was poor. For instance, only 4 of the studies in-
cluded an adequate randomization process and conceal-
ment of allocation, and a priori sample size calculations 
were rare. Only few studies were blinded. The majority of 
the studies had a maximum follow-up of 12 months, and 
many reported only the positive results. The reviewers 
concluded that the lack of adherence to best practice in 
trial-based studies on effectiveness was overwhelming. 
There was a significant but very small overall effect on 
depressive symptoms in the caregivers, which should be 
interpreted with caution. The meta-analysis did not iden-
tify any significant effect in other outcome parameters. 
The authors concluded that there is a pressing need to 
ensure that supportive interventions at the development 
stage are accompanied by good quality randomized eval-
uation in which outcomes that are important for clini-
cians and carers are measured. Subsequently, at least 1 
recent RCT on psychosocial intervention for family car-
ers was unable to identify any effect on primary outcome 
variables  [38] .
 Thus, there is a great need for randomized controlled 
studies, which takes into account these methodological 
considerations, and also for studies directed towards pa-
tients with mild dementia. The DAISY study meets all 
quality criteria established by the Cochrane group  [21, 
22] .
 Summary of Strengths and Limitations 
 In summary, the strengths of the present study are re-
lated to the quality of the rater-blinded RCT design, the 
focus on patients with mild dementia and their caregivers, 
the inclusion of patients as well as caregivers in the inter-
vention programme, the multifaceted and semitailored 
design of the intervention, the long-term follow-up and 
the unique potentials for registry-based follow-up. In ad-
dition, the study collected also qualitative data, as there is 
a risk that important aspects of supportive interventions, 
such as perceptions and attitudes concerning the pro-
gramme or staff members, adverse effects or the positive 
aspects of sharing experiences with others, may be over-
looked in quantitatively designed studies. Therefore, ex-
perience must also be gained from qualitative studies, 
which may help design future quantitative studies  [34, 39] .
 There are also limitations associated with the study. 
The study includes a broad range of patients with mild 
dementia and not only those with identified needs for 
psychosocial intervention, which could potentially lead 
to unexpected adverse effects of the intensive support 
programme. On the other hand, based on the inclusion 
criteria the patient group is selected with a high represen-
tation of patients with a supportive social network and 
may not adequately reflect the average population of AD 
patients. Because there is no established consensus on 
primary outcomes, the study is to some extent also ex-
plorative and will contribute to the design of future stud-
ies.
 Conclusion 
 There is a lack of appropriately designed trials inves-
tigating the efficacy of psychosocial interventions for 
informal carers of patients with dementia, and only few 
studies have included interventions for the patients as 
well. The DAISY study is the largest study to date to in-
vestigate the efficacy of a multifaceted psychosocial in-
tervention programme in patients with mild dementia 
and their caregivers using an RCT design. The study ap-
plies a novel semitailored approach to counselling inte-
grated in a multifaceted programme. The results of the 
ongoing study will contribute to the evidence for psy-
chosocial intervention and to the design of future inter-
ventions for patients with mild dementia and their car-
ers.
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